U.S. Residential REITs Stock News

Latest FY 2025 Earnings Snapshot Catalyst Pharmaceuticals (CPRX) just wrapped up FY 2025 with Q4 revenue of US$152.6 million and basic EPS of US$0.43, alongside net income of US$52.7 million, putting concrete numbers around its latest earnings season update. The company has seen quarterly revenue move from US$141.8 million in Q4 2024 to US$152.6 million in Q4 2025, while basic EPS shifted from US$0.47 to about US$0.43 over the same periods. Trailing twelve month EPS stands at US$1.75 and...

Axogen (AXGN) just cleared a major regulatory hurdle, securing FDA approval for Avance as the first biologic therapeutic for peripheral nerve repair. The company also received 12 years of market exclusivity and issued new 2026 sales guidance. See our latest analysis for Axogen. The FDA approval, upsized equity raise and new 2026 guidance come after a period of mixed trading, with a 1-day share price return of 2.18% and a 90-day share price return of 11.34%, while the 1-year total shareholder...

Standard Motor Products (SMP) has wrapped up FY 2025 with fourth quarter revenue of US$385.1 million and basic EPS of US$0.42, against prior year Q4 revenue of US$343.4 million and basic EPS of about a US$0.04 loss. Over the last twelve months, revenue has moved from US$1.46 billion to US$1.79 billion, while trailing basic EPS has shifted from US$2.46 to US$3.59. With net profit margin at 4.4% and the latest results pointing to sturdier profitability, the focus now is on how durable these...

Hertz Global Holdings (HTZ) closed FY 2025 with Q4 revenue of US$2,028 million and a basic EPS loss of US$0.62, alongside trailing 12 month revenue of US$8.5 billion and a net loss of US$747 million. The company has seen quarterly revenue range from US$1,813 million to US$2,478 million over the last four reported periods, while basic EPS has swung between a loss of US$1.44 and a profit of US$0.59. This backdrop is prompting investors to focus on how much of that volatility is flowing through...

If you are wondering whether Procore Technologies at around US$55.81 is priced attractively today, it helps to step back and look at how its current share price lines up with a few core valuation checks. The stock has moved 7.3% over the last 7 days, while the 30 day return sits at an 11.6% decline and the year to date return is a 20.3% decline, with a 26.5% decline over 1 year and a 16.8% decline over 3 years, which may have changed how investors view both its potential and its...

If you are wondering whether Royalty Pharma's current share price reflects its true worth, you are not alone and that is exactly what this article will help you unpack. The stock recently closed at US$45.36, with returns of 0.6% over 7 days, 11.3% over 30 days, 16.7% year to date, 39.2% over 1 year, 39.3% over 3 years and 20.4% over 5 years, which naturally raises questions about how much of this performance is already priced in. Recent news around Royalty Pharma has largely focused on its...

If you are wondering whether Packaging Corporation of America is still reasonably priced after its recent run, this article will walk through what the current share price could imply about value. The stock last closed at US$231.83, with returns of 3.7% over 30 days and 9.8% year to date, while the 1 year and 3 year returns stand at 12.8% and 79.0% respectively and the 5 year return is 100.5%. Recent coverage around the company has kept attention on how the packaging sector is positioned...

If you are wondering whether Bank of America at around US$52.30 is still a sensible entry point or starting to look expensive, you are not alone. The stock has had a mixed run, with a 0.2% move over the past month, a 21.3% return over the last year, and a 6.5% decline year to date. These moves can change how investors think about both upside and risk. Recent coverage has focused on large US banks like Bank of America as investors reassess interest rate expectations and the health of the...

Wave Life Sciences (WVE) has just closed out FY 2025 with fourth quarter revenue of US$17.2 million, a basic EPS loss of US$0.30 and net income loss of US$53.2 million, following a prior year fourth quarter that carried revenue of US$83.7 million and basic EPS of US$0.18. Over recent quarters the company has seen revenue move from US$9.2 million in Q1 2025 to US$8.7 million in Q2 and US$7.6 million in Q3, while quarterly basic EPS held in a relatively tight loss range between US$0.29 and...

Ardagh Metal Packaging (NYSE:AMBP) has wrapped up FY 2025 with fourth quarter revenue of US$1.3b and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$16m loss. Over recent periods the company has seen revenue move from US$1.2b in Q4 2024 to US$1.3b in Q4 2025, with quarterly EPS ranging between a loss of US$0.03 and a profit of roughly US$0.04, while trailing twelve month net income excluding extra items sits at US$11m on US$5.5b of revenue. With the company now...

Are you wondering whether Cabot shares offer good value at today's price, or whether you might be overpaying for the story the market is telling right now? The stock last closed at US$75.81, with returns of 1.2% over the past week, 5.9% over the past month, 13.1% year to date, an 8.6% decline over the past year, a 1.6% decline over three years, and 72.7% over five years. This pattern hints that the market's view of risk and opportunity around Cabot has shifted over time. Recent news coverage...

In late February 2026, JPMorgan Chase & Co. warned that current market conditions and some banks’ risky lending resemble the pre-2008 financial crisis, while also outlining heavy investment in AI, technology, and branch expansion alongside a very large new US$80.00 billion universal debt shelf registration and multiple bond offerings. Jamie Dimon’s twin message of caution about credit and AI-driven job disruption, paired with aggressive spending and issuance, highlights how JPMorgan is...

Sirius XM Holdings' subsidiary has launched an upsized $1.25b senior notes offering. The company is also conducting a cash tender offer for its outstanding 2026 notes. The transactions are aimed at adjusting the company's existing debt profile. Sirius XM Holdings, listed on NasdaqGS:SIRI, is reshaping part of its balance sheet with this new debt issuance and tender offer. The stock trades at $21.52, with returns of 2.3% over the past week and 6.6% over the past month, while the 1 year and...

York Space Systems (YSS) has been drawing fresh attention after reporting annual revenue of $357.46 million alongside a net income loss of $90.647 million. This combination naturally raises questions about how the stock’s current pricing reflects its risk and potential. See our latest analysis for York Space Systems. With the share price at $26.17, York Space Systems has recorded a 1-day share price return of a 1.10% decline, a 7-day share price return of an 8.40% decline, and a year-to-date...

Rollins (ROL) is back in focus after Q4 2025 organic revenue growth of 5.7% came in below expectations due to poor weather, while management outlined 2026 guidance of 9% to 11% revenue growth and higher EBITDA margins. See our latest analysis for Rollins. Rollins' share price has softened in recent weeks, with a 30 day share price return of 5.9% and a 90 day share price return of 2.8%. This comes even as its 1 year total shareholder return of 17.7% and 5 year total shareholder return of 99.6%...

Enovix (ENVX) closed FY 2025 with Q4 revenue of US$11.3 million, a basic EPS loss of US$0.16 and a net income loss of US$35.0 million. Over recent quarters the company has seen revenue move from US$9.7 million in Q4 2024 to US$11.3 million in Q4 2025, while quarterly basic EPS shifted from a loss of US$0.20 to a loss of US$0.16. This sets the stage for investors to focus on how quickly margins might tighten or widen from here. See our full analysis for Enovix. With the headline numbers on the...

Northern Oil and Gas (NOG) FY 2025 earnings snapshot Northern Oil and Gas (NOG) has wrapped up FY 2025 with fourth quarter revenue of US$419.9 million and a basic EPS loss of US$0.73, while on a trailing twelve month basis revenue sits at about US$2.0 billion and EPS is US$0.40. Over recent periods, revenue has moved from US$506.6 million and EPS of US$0.72 in Q4 2024 to the latest Q4 2025 figures. Trailing EPS has stepped down from US$5.21 a year earlier to US$0.40 now. With net profit...

Installed Building Products FY 2025 Earnings Snapshot Installed Building Products (IBP) has wrapped up FY 2025 with fourth quarter revenue of US$747.5 million and basic EPS of US$2.85, alongside net income excluding extra items of US$76.6 million as the market weighs the results against a share price of US$322.01. Over recent quarters, the company has seen quarterly revenue move between US$684.8 million and US$778.2 million, while basic EPS has ranged from US$1.65 to US$2.85 and trailing 12...

Inhibikase Therapeutics (IKT) has moved into focus after fresh FDA designations and progress in its Phase 2a trial for IkT-148009 targeting Parkinson’s disease, even as ongoing financial instability remains part of the picture. See our latest analysis for Inhibikase Therapeutics. The recent FDA designations and Phase 2a progress appear to be feeding into momentum, with a 7 day share price return of 20.11% and a 90 day share price return of 37.50%, even though the 1 year total shareholder...

USA TODAY (TDAY) has just posted its FY 2025 numbers with Q4 revenue of US$585.0 million, basic EPS of a US$0.21 loss, and a net income loss of US$30.1 million. The trailing twelve month line shows basic EPS of US$0.01 on revenue of about US$2.3 billion and net income of US$1.7 million. Over recent periods, revenue has moved between US$560.8 million and US$621.3 million a quarter, while basic EPS has ranged from a loss of US$0.27 to a gain of US$0.54. This puts the latest print in the middle...

Xencor (XNCR) has just posted its FY 2025 numbers, with Q4 revenue of US$28.2 million, a basic EPS loss of US$0.09, and net income loss of US$6.7 million, while on a trailing twelve month basis revenue came in at US$125.6 million and EPS at a loss of US$1.24 alongside a net income loss of US$91.9 million. Over recent quarters the company has seen revenue range from US$17.8 million to US$70.0 million per quarter, while basic EPS has moved between a loss of US$0.08 and a loss of US$0.73,...

Agilon health (AGL) just posted its FY 2025 numbers with Q4 revenue at US$1.6 billion and a basic EPS loss of US$0.46, capping a trailing twelve month revenue base of US$5.9 billion and a full year EPS loss of US$0.98. The company has seen quarterly revenue move between US$1.4 billion and US$1.6 billion over the last six quarters, while basic EPS has ranged from a small quarterly loss of US$0.00 in early 2025 to a loss of US$0.46 in the latest period, keeping profitability firmly in the red...

Pursuit Attractions and Hospitality (PRSU) closed FY 2025 with Q4 revenue of US$57.1 million and a basic EPS loss of US$0.90, highlighting a softer quarter following Q3 revenue of US$241.0 million and EPS of US$2.71. Over the past year, the trailing twelve month picture shows revenue of US$452.4 million and basic EPS of US$0.88, compared with the prior trailing period that reported a basic EPS loss of US$7.03 and revenue of US$366.5 million. For investors, the combination of quarterly...

Confluent, NasdaqGS:CFLT, has introduced Confluent Intelligence and Streaming Agents, a new AI integration for its data streaming platform. The update adds real-time orchestration between AI agents and advanced Multivariate Anomaly Detection for enterprise data streams. The company’s recent product news arrives with the stock at a share price of $30.63. For investors watching enterprise data infrastructure, Confluent’s new AI oriented capabilities aim to deepen its role as a core data...